O'Donnell Niall

CIK 00017802353 companiesST. LOUIS, MO

SEC Profile

Transactions

Companies

Filings

CIK

0001780235

Recent Transactions

26 trades

Award
OnKure Therapeutics, Inc.$OKUR
Stock Option (right to buy)
2023-06-06+17,500→ 17,500 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2023-05-25+30,000→ 30,000 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2023-05-08$8.00/sh+125,000→ 2,188,713 total
Purchase
SPRUCE BIOSCIENCES, INC.$SPRB
Common Stock Warrant (Right to Buy)
2023-02-16+472,800→ 472,800 total
Purchase
SPRUCE BIOSCIENCES, INC.$SPRB
Common Stock
2023-02-16$3.17/sh+630,400→ 1,326,305 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2022-11-15$19.69/sh−93,770→ 1,621,118 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2022-11-14$19.60/sh−32,109→ 1,714,888 total
Sale
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2022-11-11$19.99/sh−174,121→ 1,746,997 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2022-06-02+17,000→ 17,000 total
Award
OnKure Therapeutics, Inc.$OKUR
Stock Option (right to buy)
2022-06-01+17,500→ 17,500 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2022-05-25+22,500→ 22,500 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2021-06-04+17,000→ 17,000 total
Award
SPRUCE BIOSCIENCES, INC.$SPRB
Stock Option (Right to Buy)
2021-05-20+10,000→ 10,000 total
Conversion
OnKure Therapeutics, Inc.$OKUR
Series A Preferred Stock
2021-04-13−4,629,630→ 0 total
Conversion
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-04-13+1,034,600→ 1,034,600 total
Conversion
OnKure Therapeutics, Inc.$OKUR
Series B Preferred Stock
2021-04-13−3,710,116→ 0 total
Conversion
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-04-13+829,113→ 1,863,713 total
Purchase
OnKure Therapeutics, Inc.$OKUR
Common Stock
2021-04-13$15.00/sh+200,000→ 2,063,713 total
Award
OnKure Therapeutics, Inc.$OKUR
Stock Option (right to buy)
2021-04-08+14,000→ 14,000 total
Purchase
SPRUCE BIOSCIENCES, INC.$SPRB
Common Stock
2020-10-14$15.00/sh+250,000→ 695,905 total
Conversion
SPRUCE BIOSCIENCES, INC.$SPRB
Series B Preferred Stock
2020-10-14−2,916,664→ 0 total
Conversion
SPRUCE BIOSCIENCES, INC.$SPRB
Common Stock
2020-10-14+445,905→ 445,905 total
Award
Mirum Pharmaceuticals, Inc.$MIRM
Stock Option (right to buy)
2020-06-11+17,000→ 17,000 total
Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2019-07-22+1,496,118→ 1,621,118 total
Conversion
Mirum Pharmaceuticals, Inc.$MIRM
Series A Preferred Stock
2019-07-22−11,968,944→ 0 total
Purchase
Mirum Pharmaceuticals, Inc.$MIRM
Common Stock
2019-07-22$15.00/sh+300,000→ 1,921,118 total

Companies

Recent Filings

Address

C/O RIVERVEST VENTURE PARTNERS 101 SOUTH HANLEY ROAD, STE. 1850

ST. LOUIS, MO, 63105

View on SEC.gov